Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial

Frater J. et al, (2021), The Lancet HIV, 8, e474 - e485

HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation.

Gupta RK. et al, (2019), Nature, 568, 244 - 248

Virological remission after antiretroviral therapy interruption in female African HIV seroconverters

Gossez M. et al, (2019), AIDS, 33, 185 - 197

A randomised controlled trial comparing the impact of antiretroviral therapy (ART) with a "Kick-and-Kill" approach to ART alone on HIV reservoirs in individuals with primary HIV infection (PHI); RIVER trial

Fidler S. et al, (2018), JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 21, 155 - 155

Follicular CD8+T-cells in gut-associated lymphoid tissue are associated with lower HIV-1 reservoir in the terminal ileum after ART initiated during primary HIV infection

Thornhill JP. et al, (2018), JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 21, 96 - 96

CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA

Martin GE. et al, (2018), Frontiers in Immunology, 9

CD32 is enriched on CD4(+) T-cells with a T-follicular

Thornhill J. et al, (2018), HIV MEDICINE, 19, S10 - S10

The impact of immunoglobulin in acute HIV infection on the HIV reservoir: a randomized controlled trial

Tiraboschi J. et al, (2017), HIV MEDICINE, 18, 777 - 781

The impact of immunoglobulin in acute HIV infection on the HIV reservoir: a randomized controlled trial

Tiraboschi J. et al, (2017), HIV Medicine, 18, 777 - 781

Early antiretroviral therapy reduces HIV DNA following perinatal HIV infection

Foster C. et al, (2017), AIDS, 31, 1847 - 1851

Early antiretroviral therapy reduces HIV DNA following perinatal HIV infection

Foster C. et al, (2017), AIDS, 31, 1847 - 1851

Enrichment of the HIV reservoir in CD32+CD4 T cells occurs early and is closely associated with immune checkpoint receptor expression

Martin GE. et al, (2017), JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 20, 103 - 103

Short Communication: Lack of Effect of Maraviroc Intensification on Blood and Gut Reservoir

Tiraboschi J. et al, (2017), AIDS Research and Human Retroviruses, 33, 143 - 146

Human endogenous retrovirus (HERV) expression is not induced by treatment with the histone deacetylase (HDAC) inhibitors in cellular models of HIV-1 latency

Hurst T. et al, (2016), Retrovirology, 13

Nonprogressing HIV-infected children share fundamental immunological features of nonpathogenic SIV infection

Muenchhoff M. et al, (2016), Science Translational Medicine, 8, 358ra125 - 358ra125

Histone Deacetylase Inhibitors Enhance CD4 T Cell Susceptibility to NK Cell Killing but Reduce NK Cell Function

Pace M. et al, (2016), PLOS Pathogens, 12, e1005782 - e1005782

The effect of Maraviroc intensification on gut reservoir and immune function in HIV-1-infected individuals receiving antiretroviral therapy with suboptimal CD4+T cell recovery

Tiraboschi J. et al, (2016), HIV MEDICINE, 17, 19 - 19

Tenofovir Disoproxil Fumarate Fails to Prevent HIV Acquisition or the Establishment of a Viral Reservoir: Two Case Reports

Fox J. et al, (2016), Infectious Diseases and Therapy, 5, 65 - 71

Immunological biomarkers predict HIV-1 viral rebound after treatment interruption

Hurst J. et al, (2015), Nature Communications, 6

Hidden Menace

Martin G. et al, (2015), SCIENTIST, 29, 34 - 39

Load More

Include forthcoming?